文献速递针灸推拿中医康复中医内科

针灸在COVID-19治疗、预防与康复中的作用:范围综述

The role of acupuncture and moxibustion in the treatment, prevention, and rehabilitation of patients with COVID-19: A scoping review.
PubMed 文献 · Integr Med Res · 2022-08-08

本研究通过范围综述总结针灸用于COVID-19治疗、预防和康复的现有证据及指南共识推荐。共纳入131项研究,主题以治疗(82.4%)和预防(38.9%)为主;18项指南共识共给出47条针灸推荐,聚焦治疗(44.7%)、康复(36.2%)和预防(12.8%)。结论认为针灸在一定程度上有效,但仍需高质量临床试验确定其可行性。

要点

  • 针灸用于COVID-19的证据以文献综述和系统评价方案为主,高质量临床 trials 不足。
  • 18项指南共识给出47条针灸推荐,治疗占44.7%、康复占36.2%、预防占12.8%。
  • 治疗、康复和预防分别最常推荐足三里(ST36)、肺俞(BL13)和关元(RN4)。

核心结论

  • 针灸在一定程度上对COVID-19患者治疗有效,但仍需更多高质量临床试验确定其可行性以更好指导临床实践。

研究设计与样本

  • 范围综述,检索8个电子数据库及其他相关网站,最终纳入131项符合条件的研究。

主要发现

  • 纳入研究的主要主题为COVID-19治疗(82.4%)和预防(38.9%)。
  • 纳入研究类型以文献综述(65项,49.6%)、系统评价方案(20项,15.3%)和指南共识(18项,13.7%)为主。
  • 18项指南共识共包含47条针灸推荐,其中治疗21条(44.7%)、康复17条(36.2%)、预防6条(12.8%)。
  • 治疗最常推荐足三里(ST36),康复最常推荐肺俞(BL13),预防最常推荐关元(RN4)。

关键数值与推荐

  • 47条推荐中治疗占21/47(44.7%),康复占17/47(36.2%),预防占6条(12.8%)。
  • 治疗最常推荐穴位为足三里(ST36),康复为肺俞(BL13),预防为关元(RN4)。

临床怎么用

  • 临床可参考指南共识推荐,在COVID-19治疗中优先考虑足三里(ST36),康复中考虑肺俞(BL13),预防中考虑关元(RN4)。
  • 应结合现有低质量证据谨慎应用针灸,并关注高质量临床试验的更新结果。

局限性

  • 纳入研究以文献综述和系统评价方案为主,高质量临床 trials 不足,证据等级有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: This study aims to summarize the available evidence and guideline/consensus recommendations for acupuncture and moxibustion in the treatment, prevention and rehabilitation of patients with coronavirus disease 2019 (COVID-19). METHODS: A scoping review was performed. Eight electronic databases and other related websites were searched. All studies related to acupuncture and moxibustion for COVID-19 were considered. Descriptive analysis was applied to analyze the all included studies and guideline recommendations. RESULTS: We ultimately included 131 eligible studies. The main topics of the included studies were the treatment (82.4%) and prevention (38.9%) of COVID-19. The most included studies were literature reviews (65, 49.6%), protocols of systematic reviews (20, 15.3%), and guidelines and consensuses (18, 13.7%). The 18 (13.7%) COVID-19 guidelines and consensuses included 47 recommendations on acupuncture and moxibustion, which focused on the treatment (21/47, 44.7%), rehabilitation (17/47, 36.2%) and prevention (6, 12.8%) of COVID-19 patients. Zusanli (ST36), Feishu (BL13), Guanyuan (RN4) were recommended mostly for the treatment, rehabilitation and prevention respectively. CONCLUSION: Acupuncture and moxibustion are effective in the treatment of COVID-19 patients to some extent. However, more high-quality of clinical trials still needed to determine the feasibility of acupuncture and moxibustion in COVID-19 patients to better guide clinical practice. STUDY REGISTRATION: Open Science Framework Registries (Registration DOI: 10.17605/OSF.IO/Z35WN; https://osf.io/z35wn).

来源:Integr Med Res,查看原文。版权归原作者所有。

引用

  1. Ren M, Liu Y, Ni X, et al. The role of acupuncture and moxibustion in the treatment, prevention, and rehabilitation of patients with COVID-19: A scoping review. Integr Med Res. 2022. PMID: 35967901. doi:10.1016/j.imr.2022.100886

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。